Six‐month results of a double‐blind, placebo‐controlled trial of etanercept treatment in patients with active ankylosing spondylitis

The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

1992 • 33,264 citations

The MOS 36-ltem Short-Form Health Survey (SF-36)

1992 • 26,794 citations

Evaluation of Diagnostic Criteria for Ankylosing Spondylitis

1984 • 5,334 citations

Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent

2001 • 3,631 citations

A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index.

1994 • 3,015 citations

A new approach to defining functional ability in ankylosing spondylitis: the development of the Bath ankylosing spondylitis functional index

2001 • 1,789 citations

Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial

2000 • 1,463 citations

Etanercept Therapy in Rheumatoid Arthritis

1999 • 1,407 citations

Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial

2002 • 1,272 citations

Defining spinal mobility in ankylosing spondylitis (AS). The Bath AS Metrology Index.

1994 • 961 citations

Etanercept for active Crohn's disease: A randomized, double-blind, placebo-controlled trial

2001 • 910 citations

Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors

1998 • 892 citations

Demyelination occurring during anti-tumor necrosis factor ? therapy for inflammatory arthritides

2001 • 813 citations

Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis

1995 • 686 citations

Treatment of Ankylosing Spondylitis by Inhibition of Tumor Necrosis Factor α

2002 • 679 citations

Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis

2001 • 602 citations

Successful treatment of active ankylosing spondylitis with the anti–tumor necrosis factor α monoclonal antibody infliximab

2000 • 492 citations

TREATMENT OF ANKYLOSING SPONDYLITIS BY INHIBITION OF TUMOR NECROSIS FACTOR a

2002 • 482 citations

Life‐threatening histoplasmosis complicating immunotherapy with tumor necrosis factor α antagonists infliximab and etanercept

2002 • 444 citations

Magnetic resonance imaging examinations of the spine in patients with ankylosing spondylitis, before and after successful therapy with infliximab: Evaluation of a new scoring system

2003 • 400 citations

Disability and handicap in rheumatoid arthritis and ankylosing spondylitis--results from the German rheumatological database. German Collaborative Arthritis Centers.

2000 • 325 citations

The bath ankylosing spondylitis radiology index (BASRI): A new, validated approach to disease assessment

1998 • 313 citations

Efficacy of etanercept in the treatment of the entheseal pathology in resistant spondylarthropathy: A clinical and magnetic resonance imaging study

2001 • 305 citations

Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: A Department of Veterans Affairs cooperative study

1999 • 305 citations

Health-related quality of life in ankylosing spondylitis: A survey of 175 patients

1999 • 303 citations

Efficacy of celecoxib, a cyclooxygenase 2-specific inhibitor, in the treatment of ankylosing spondylitis: A six-week controlled study with comparison against placebo and against a conventional nonsteroidal antiinflammatory drug

2001 • 247 citations

Preliminary core sets for endpoints in ankylosing spondylitis. Assessments in Ankylosing Spondylitis Working Group.

1997 • 243 citations

Prevalence of ankylosing spondylitis in males and females in a young middle-aged population of Tromso, northern Norway.

1985 • 231 citations

Employment, work disability, and work days lost in patients with ankylosing spondylitis: a cross sectional study of Dutch patients

2001 • 208 citations

RADIOLOGIC DIAGNOSIS AND PATHOLOGY OF THE SPONDYLOARTHROPATHIES

1998 • 202 citations

Ileocolonoscopic Findings in Seronegative Spondylarthropathies

1988 • 178 citations

Pathogenesis of spondylarthropathies

1995 • 171 citations

Ankylosing spondylitis: what is the optimum duration of a clinical study? A one year versus a 6 weeks non-steroidal anti-inflammatory drug trial

1999 • 158 citations

PROGNOSIS, COURSE OF DISEASE, AND TREATMENT OF THE SPONDYLOARTHROPATHIES

1998 • 142 citations

The national database of the German Collaborative Arthritis Centres: I. Structure, aims, and patients

2001 • 132 citations

Sulfasalazine in the treatment of ankylosing spondylitis

1988 • 127 citations

Therapy of ankylosing spondylitis and other spondyloarthritides: established medical treatment, anti-TNF-alpha therapy and other novel approaches.

2002 • 119 citations

Efficacy of etanercept for treatment of Crohn's related spondyloarthritis but not colitis

2002 • 110 citations

Course of gut inflammation in spondylarthropathies and therapeutic consequences

1996 • 103 citations

Enthesitis and ankylosis in spondyloarthropathy: What is the target of the immune response?

2000 • 93 citations

Employment perspectives of patients with ankylosing spondylitis

2002 • 83 citations

Update: the twenty subtypes of HLA-B27

2000 • 69 citations

Treatment of ankylosing spondylitis with disease modifying antirheumatic drugs.

2002 • 39 citations

Methotrexate Lacks Efficacy in the Treatment of Severe Ankylosing Spondylitis Compared with Rheumatoid and Psoriatic Arthritis

1998 • 26 citations

Treatments Used by Patients with Ankylosing Spondylitis Comparison with the Treatment Preferences of Rheumatologists

1999 • 23 citations